CTRI/2014/02/004432
Completed
Phase 4
An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- subjects with mild asthma or COPD
- Sponsor
- Cipla Ltd
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Subjects and healthy volunteers willing to sign ethics committee
- •approved informed consent form.
- •2\. Subjects and healthy volunteers of 18 years and above.
- •3\. Subjects with or without a respiratory condition. Each subject with a
- •respiratory condition (prior experience of using a device) should be
- •matched as far as possible with an individual without a respiratory
- •condition (device naive) with respect to the age, sex, literacy status
- •4\. Subjects with mild Asthma or COPD or healthy volunteer.
Exclusion Criteria
- •1\. Subjects already using Zerostat\-VT spacer prior to start of the study.
- •2\. Subjects with co\-ordination problems like Parkinsonâ??s disease,
- •mental illness, tremors etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Subjects with mild Asthma or COPD or healthy volunteer.CTRI/2014/03/004448Cipla Ltd30
Completed
Phase 4
A clinical trial to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.CTRI/2009/091/000958Cipla Ltd30
Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat-V spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Healthy volunteers and subjects with mild Asthma orCOPD.CTRI/2014/03/004462Cipla Ltd30
Completed
Phase 4
A clinical trial to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.CTRI/2009/091/000586Cipla Ltd30
Active, not recruiting
Phase 1
Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABASEUCTR2017-004608-22-FRCHU de Nice28